Americas to Dominate Newborn Screening Market

Market Analysis:

Newborn screening, simply put, are medical tests, most of which are genetic, carried out for identifying babies having specific disorders that without intervention is likely to affect newborns as well as their families permanently.

Global New-Born Screening Market is expected to register a CAGR of 13.33% to reach USD 1545.98 Million till 2025.

Various factors are propelling the newborn screening market growth. Some of these factors, according to the Market Research Future report, include the rising base of neonatal population, favorable government policies, various technological advancements, and increasing government initiatives for research and development. Additional factors pushing market growth include growing demand for early disease detection tests, rising number of neonatal diseases including congenital hypothyroidism and newborn hearing loss, and rising cases of critical congenital heart defects.

On the contrary, absence of infrastructure, different socio-economic restraints, the high cost of automation technology, and lack of uniformity of newborn screening procedures and policies are factors that may restrict the newborn screening market growth over the forecast period.

Key Players:

·         ZenTech S.A

·         Trivitron Healthcare

·         GE Healthcare

·         Covidien PLC

·         Bio-Rad Laboratories

·         Agilent Technologies

·         Masimo Corporation

·         Natus Medical Incorporated

·         Waters Corporation

·         Perkinelme

·         AB Sciex LLC

Market Segmentation:

The Global New-Born Screening Market has been segmented into product, technology, test type, and end user.

The Global New-Born Screening Market by products has been segregated into instruments and reagents and assay kits. The instruments segment is expected to grow owing to the increasing awareness about new-born screening and subsequently increasing the number of new-born screening tests

The Global New-Born Screening Market by technology has been divided into tandem mass spectrometry, DNA assays, electrophoresis, pulse oximetry, immunoassays and enzymatic assays, and hearing screening technology.

The Global New-Born Screening Market, by test type, has been classified as dry blood spot test, critical congenital heart disease (CCHD) test, urine test, and hearing screening test.

The global new-born screening market, by end user, has been categorized as hospitals, maternity and specialty clinics, diagnostic centers, and others.

Regional Analysis:

Based on region, the newborn screening market report covers the latest trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will dominate the market over the forecast period. This is owing to medical tourism, technological advancements, and rising healthcare awareness.

The newborn screening market in Europe is predicted to have the second-largest share in the market over the forecast period. This is owing to growing government funding for newborn screening.

The newborn screening market in the APAC region is predicted to grow at the fastest pace over the forecast period. This is owing to favorable healthcare schemes that are drafted by government agencies, quality assurance, and awareness programs of newborn diagnostic procedures. Sri Lanka, China, Taiwan, and Korea are the key contributors in the region.

The newborn screening market in the MEA is predicted to have minimal share over the forecast period. This is owing to low per capita income and strict government policies.